Loss of LRRC33-dependent TGFbeta1 activation enhances anti-tumor immunity and checkpoint blockade therapy.
Jiang A, Qin Y, Springer TA
Cancer Immunol Res. 2022 Feb 18. pii: 681626. doi: 10.1158/2326-6066.CIR-21-0593.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
| ID | Plasmid | Purpose |
|---|---|---|
| 180258 | pD2529-CAG-HA-mouse GARP | Mouse full length GARP expression |
| 180259 | pD2529-CAG-HA-mouse LRRC33 | Mouse full length LRRC33 expression |
| 180260 | pD2529-CAG-Flag-mouse TGFb1 | Mouse full length TGFβ1 expression |
| 180261 | PD2529-CAG-Flag-mouse TGFb2 | Mouse full length TGFβ2 expression |
| 180262 | pD2529-CAG-Flag-mouse TGFb3 | Mouse full length TGFβ3 expression |